These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8810580)

  • 1. In vitro percutaneous absorption of piroxicam through synthetic membranes and abdominal rat skin.
    Santoyo S; Arellano A; Ygartua P; Martín C
    Pharm Acta Helv; 1996 Jul; 71(2):141-6. PubMed ID: 8810580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeation of piroxicam from the poloxamer gels.
    Shin SC; Cho CW; Choi HK
    Drug Dev Ind Pharm; 1999 Mar; 25(3):273-8. PubMed ID: 10071819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application.
    Santoyo S; Ygartua P
    Eur J Pharm Biopharm; 2000 Sep; 50(2):245-50. PubMed ID: 10962234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats.
    Shin S; Cho C; Oh I
    Int J Pharm; 2000 Jan; 193(2):213-8. PubMed ID: 10606784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical piroxicam in vitro release and in vivo anti-inflammatory and analgesic effects from palm oil esters-based nanocream.
    Abdulkarim MF; Abdullah GZ; Chitneni M; Salman IM; Ameer OZ; Yam MF; Mahdi ES; Sattar MA; Basri M; Noor AM
    Int J Nanomedicine; 2010 Nov; 5():915-24. PubMed ID: 21116332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam.
    Doliwa A; Santoyo S; Ygartua P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(2):97-107. PubMed ID: 11316968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing effects of fatty acids on piroxicam permeation through rat skins.
    Shin SC; Shin EY; Cho CW
    Drug Dev Ind Pharm; 2000 May; 26(5):563-6. PubMed ID: 10789070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.
    Doliwa A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin.
    Larrucea E; Arellano A; Santoyo S; Ygartua P
    Eur J Pharm Biopharm; 2001 Sep; 52(2):113-9. PubMed ID: 11522475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of tenoxicam with cyclodextrins and its influence on the in vitro percutaneous penetration of the drug.
    Larrucea E; Arellano A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001; 27(3):251-60. PubMed ID: 11291205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application.
    Gupta SK; Bansal P; Bhardwaj RK; Jaiswal J; Velpandian T
    Skin Pharmacol Appl Skin Physiol; 2002; 15(2):105-11. PubMed ID: 11867967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of reverse micelle based organogels of piroxicam.
    Agrawal GP; Juneja M; Agrawal S; Jain SK; Pancholi SS
    Pharmazie; 2004 Mar; 59(3):191-3. PubMed ID: 15074590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive LC determination of piroxicam after in vitro transdermal permeation studies.
    Doliwa A; Santoyo S; Campanero MA; Ygartua P
    J Pharm Biomed Anal; 2001 Nov; 26(4):531-7. PubMed ID: 11516903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro release studies of piroxicam from oil-in-water creams and hydroalcoholic gel topical formulations.
    Rafiee-Tehrani M; Mehramizi A
    Drug Dev Ind Pharm; 2000 Apr; 26(4):409-14. PubMed ID: 10769782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect.
    Dalmora ME; Dalmora SL; Oliveira AG
    Int J Pharm; 2001 Jul; 222(1):45-55. PubMed ID: 11404031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of penetration enhancers on in vitro percutaneous penetration of nimesulide through rat skin.
    Güngör S; Bergişadi N
    Pharmazie; 2004 Jan; 59(1):39-41. PubMed ID: 14964420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins.
    Shin SC; Cho CW; Oh IJ
    Int J Pharm; 2001 Jul; 222(2):199-203. PubMed ID: 11427350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers.
    Tas C; Ozkan Y; Okyar A; Savaser A
    Drug Deliv; 2007 Oct; 14(7):453-9. PubMed ID: 17994363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels.
    Arellano A; Santoyo S; Martín C; Ygartua P
    Eur J Pharm Sci; 1999 Jan; 7(2):129-35. PubMed ID: 9845796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical absorption of piroxicam from organogels--in vitro and in vivo correlations.
    Pénzes T; Blazsó G; Aigner Z; Falkay G; Eros I
    Int J Pharm; 2005 Jul; 298(1):47-54. PubMed ID: 15893893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.